Watch Philadelphia CyberKnife Medical Director John Lamond, M.D. talk about how Philadelphia CyberKnife was the first to bring CyberKnife technology to the greater Philadelphia region over ten years ago. They are the most experienced CyberKnife team in the area and you can trust them to treat your prostate cancer in five nonsurgical treatment sessions. It's Your Prostate. Your Cancer. Your Choice. For more information on how Philadelphia CyberKnife treats prostate cancer with CyberKnife technology, please call 888-CyberMe or visit www.MyCyberKnife.com today!
A recent article from CancerConnect.com, a patient-focused cancer website, suggests that if you have been diagnosed with cancer, seeking a second opinion will allow you to learn more about your cancer type and make truly informed decisions about treatment.
The American Society for Radiation Oncology (ASTRO), the premier radiation oncology society in the world, recently updated their guidelines for accelerated partial breast irradiation (APBI) in the treatment of patients with early-stage breast cancer.
On Thursday, September 8, the physicians and staff from Philadelphia CyberKnife hosted a survivorship celebration to recognize and honor the cancer survivors treated at the center.
Philadelphia CyberKnife announced that Olusola Obayomi-Davies, M.D. will be joining their cancer care treatment team.
Recently, Philadelphia CyberKnife, in cooperation with the department of Radiation Medicine at Georgetown University Hospital, started to evaluate accelerated partial breast irradiation delivered with the CyberKnife® Robotic Radiosurgery System in early stage breast cancer in five treatments through a registry study.
Alliance Oncology, a division of Alliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced healthcare services, announced today that Luther W. Brady, M.D. is being made an Extraordinary International Academic Member of the Spanish Royal Academy of Medicine.
Greg Spurlock, President of Alliance Oncology, announced today that Luther W. Brady M.D., Director of Medical Research at The CyberKnife Center of Philadelphia, is being awarded his seventh honorary degree from Complutense University in Madrid, Spain.
Crozer-Keystone Health System recently issued a press release about a new study that has found that the CyberKnife Robotic Radiosurgery System is able to offer prostate cancer patients success rates equal to intensity modulated radiation therapy (IMRT), with shorter treatment duration and lower total cost.